APT(SH:688617)2024-04-25 08:11Financial Performance - The company's operating revenue for Q1 2024 reached ¥455,327,284.53, representing a year-on-year increase of 30.20%[4] - The net profit attributable to shareholders of the listed company was ¥140,143,827.76, up 36.48% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥136,530,234.33, reflecting a 51.59% increase year-on-year[4] - Basic earnings per share for the period were ¥2.10, an increase of 36.36%[5] - In Q1 2024, the company reported a net profit of ¥137,859,486.16, an increase of 39.5% compared to ¥98,783,915.48 in Q1 2023[22] - The total profit for Q1 2024 was ¥157,681,803.90, up from ¥115,659,270.08 in Q1 2023, reflecting a growth of 36.3%[22] - Operating profit for Q1 2024 reached ¥157,984,438.08, compared to ¥115,829,331.64 in the same period last year, marking an increase of 36.3%[22] - The company's basic earnings per share for Q1 2024 were ¥2.10, up from ¥1.54 in Q1 2023, reflecting a growth of 36.4%[22] - The diluted earnings per share for Q1 2024 were ¥2.07, compared to ¥1.52 in Q1 2023, an increase of 36.2%[22] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,608,084,529.11, a 1.36% increase from the end of the previous year[5] - Total assets as of March 31, 2024, amounted to RMB 2,608,084,529.11, a slight increase from RMB 2,572,982,295.44 at the end of 2023[20] - Total liabilities decreased to ¥504,895,145.28 in Q1 2024 from ¥610,981,432.09 in Q4 2023, indicating a reduction of approximately 17.3%[19] - The company's total equity increased to ¥2,103,189,383.83 as of March 31, 2024, compared to ¥1,962,000,863.35 at the end of 2023[20] Cash Flow - The cash flow from operating activities was ¥114,587,998.06, showing a slight decrease of 1.51% compared to the previous year[4] - The company generated cash inflows from operating activities totaling ¥516,004,846.47 in Q1 2024, compared to ¥424,986,539.90 in Q1 2023, representing a growth of 21.4%[24] - Cash outflows from operating activities were ¥401,416,848.41 in Q1 2024, up from ¥308,639,487.72 in Q1 2023, indicating an increase of 30.0%[24] - The net cash flow from operating activities was ¥114,587,998.06, slightly down from ¥116,347,052.18 in Q1 2023, a decrease of 1.5%[24] - The company reported cash outflows from investing activities of ¥743,834,976.44 in Q1 2024, compared to ¥815,102,562.26 in Q1 2023, a decrease of 8.8%[25] - The net cash flow from investing activities was -¥663,726,415.81 in Q1 2024, compared to ¥74,169,935.15 in Q1 2023, indicating a significant decline[25] Research and Development - The company's R&D investment totaled ¥65,615,307.81, which is 14.41% of operating revenue, a decrease of 0.63 percentage points year-on-year[5] - Research and development expenses increased to ¥65,615,307.81 in Q1 2024, compared to ¥52,606,928.37 in Q1 2023, reflecting a 24.7% rise[21] Market Expansion - The company actively expanded both domestic and international markets, leading to increased product coverage and sales growth[9] Shareholding Structure - The total shares transferred to Shenzhen Mindray Biomedical Electronics Co., Ltd. amounted to 13,185,240 shares, representing 19.72% of the company's total equity[15] - Shenzhen Mindray directly holds 14,120,310 shares, accounting for 21.12% of the total shares, while its action in concert, Zhuhai Tongsheng, holds 2,335,296 shares, or 3.49%[16] - The total shareholding of Shenzhen Mindray and Zhuhai Tongsheng combined is 16,455,606 shares, which is 24.61% of the total equity[16] - The company reported a total of 74,900 shares in the securities lending program at the end of the reporting period[14] - The proportion of shares held by China Bank - Huabao CSI Medical ETF increased from 1.93% to 1.95% during the reporting period[14] - The company has not reported any changes in the top 10 shareholders due to securities lending or repayment reasons[14] - The company’s major shareholders include entities with a combined holding of over 5%, indicating a concentrated ownership structure[15]